Sapient Discovery is a drug discovery company that leverages advanced technologies such as X-ray crystallography and virtual screening to enhance the identification and optimization of lead molecules targeting therapeutic proteins. The company employs a unique approach that integrates computational chemistry and structural biology, allowing for the rapid definition of molecular structures from gene sequences. This process utilizes proprietary algorithms and experimental data to create protein structures that serve as templates for drug design, effectively bridging the gap between target discovery and the necessary 3D structural coordinates required for drug development.

The company's innovative methodologies include the Genes to Leads™ virtual screening technology, Augmented Homology Modeling™, and X-ray crystallography, which collectively facilitate the swift and cost-effective identification of novel small molecule inhibitors for various protein targets. With a strong emphasis on collaboration, Sapient Discovery offers its expertise to biotechnology firms, pharmaceutical companies, and academic institutions, providing consulting services and support in drug discovery efforts. Their facilities in San Diego are equipped with state-of-the-art computational and laboratory resources, enabling them to conduct comprehensive structure-based design and screening activities.

United States

Contract Small Molecule Discovery & Services

Sapient Discovery

Sapient Discovery

Company Details